The efficacy of standard laxative use for the prevention and treatment of opioid induced constipation during oxycodone use: a small Dutch observational pilot study.
about
Pharmacologic Profile of Naloxegol, a Peripherally Acting µ-Opioid Receptor Antagonist, for the Treatment of Opioid-Induced Constipation.Peripherally acting μ-opioid receptor antagonists as treatment options for constipation in noncancer pain patients on chronic opioid therapy.Oral prolonged-release oxycodone/naloxone for managing pain and opioid-induced constipation: A review of the evidence.Treatment With Naloxegol Versus Placebo: Pain Assessment in Patients With Noncancer Pain and Opioid-Induced Constipation.Prolonged-release oxycodone/naloxone reduces opioid-induced constipation and improves quality of life in laxative-refractory patients: results of an observational study.
P2860
The efficacy of standard laxative use for the prevention and treatment of opioid induced constipation during oxycodone use: a small Dutch observational pilot study.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
2015年论文
@zh
2015年论文
@zh-cn
name
The efficacy of standard laxat ...... tch observational pilot study.
@en
type
label
The efficacy of standard laxat ...... tch observational pilot study.
@en
prefLabel
The efficacy of standard laxat ...... tch observational pilot study.
@en
P2093
P2860
P1476
The efficacy of standard laxat ...... tch observational pilot study.
@en
P2093
Frank J P M Huygen
Gineke Koopmans-Klein
Hans C H Wartenberg
Michel F M Wagemans
Yvonne J B Van Megen
P2860
P304
P356
10.1586/17474124.2016.1129275
P577
2015-12-05T00:00:00Z